Bright Minds Biosciences Inc (DRUG) Stock Price, Quote & News

Company Profile

Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio of selective 5-HT receptor agonists includes 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry; and BMB-101 which completes phase 1 trial for undisclosed seizure disorder. The company also develops BMB-201 and BMB-202 for the treatment of neuropsychiatry and neurology indicatio...

Industry: Biotechnology

Sector: Healthcare

Phone: 647 865 8622

Website: brightmindsbio.com

Address:

19 Vestry Street, New York, United States

BiotechBonesaw Dec. 4 at 8:58 PM

$VKTX $QNTM $IMRX $DRUG get ready 😳 https://www.investors.com/news/technology/medical-stocks-biotech-stocks-research-stocks-fda-clinical-trials/

0 · Reply

Stock_Catcher Dec. 4 at 2:56 AM

Money Thursday Watchlist Pt 9 $BBBY $ETHZ $OGEN $OPGN $DRUG Let's Ride Tomorrow 📈

0 · Reply

dbr_island Dec. 3 at 11:14 PM

$PLRZ told you this was a special ticker $EPOW will be another special one that will go BOOM I even called $DRUG in the $2’s👇💰💰💰💰 MARK THIS POST $KITT $KALA

0 · Reply

dbr_island Dec. 3 at 10:57 PM

$DRUG as you can see below I see things others don’t That’s why I’m POUNDING the table on $EPOW 🚨👇 WATCH AND LEARN $GNS $BURU $IXHL let’s keep going bulls

1 · Reply

dbr_island Dec. 3 at 10:49 PM

$DRUG you ignored me here in the $2’s $EPOW I’m telling you this is the next BIG runner 🚨🚨 $30 MILLION contract folks👇💰💰💰 That should put EPOW at around $2 🎯✅ $KITT $KALA $WNW what a day

0 · Reply

Doozio Dec. 3 at 3:29 PM

All the $DRUG zzzz out of the 1st 🐑 correction of 🐒🍌🧠⏰♾️

0 · Reply

Stock__Hunter Dec. 2 at 8:44 PM

$DRUG top of line ticker name.. pro tip.. stay away from junkie ticker names

0 · Reply

Stock__Hunter Dec. 2 at 8:41 PM

$DRUG Biosciences need more... bio.. drug...

0 · Reply

PolycarpFX Dec. 2 at 8:28 PM

$DRUG printed an important BLOCK on a DARK POOL on 2025-12-02 @ 14:58:00 EST via @_VolumeLeaders_

0 · Reply

Doozio Dec. 2 at 5:27 PM

What if da $DRUG zzzzz are $YEXT ?

0 · Reply

Bright Minds Biosciences to Present at Piper Sandler 37th Annual Healthcare Conference and 2025 AES Annual Meeting

Nov 17, 2025, 5:29 PM EST - 17 days ago

Why Bright Minds Biosciences Stock Topped the Market on Monday

Nov 17, 2025, 6:50 AM EST - 17 days ago

Bright Minds Biosciences Expands Scientific Advisory Board to Include Renowned Experts in Prader-Willi Syndrome (PWS)

Nov 6, 2025, 6:30 AM EST - 4 weeks ago

Bright Minds Biosciences Initiates New Prader-Willi Syndrome (PWS) Program; KOL Event Scheduled for November 6TH

May 20, 2025, 8:00 AM EDT - 7 months ago

Bright Minds Biosciences Announces Featured Speakers for its Absence Epilepsy Virtual R&D Day on May 20, 2025

May 7, 2025, 4:45 PM EDT - 7 months ago

Epilepsy-Focused Bright Minds Biosciences A High-Risk, High-Reward Play, Analyst Initiates With Over 150% Stock Upside

Apr 28, 2025, 8:00 AM EDT - 7 months ago

Bright Minds Biosciences to Host Virtual R&D Day on May 20, 2025; Program Highlights Include an Overview of Absence Seizures and the BMB-101 Phase 2 Study

Apr 16, 2025, 12:09 PM EDT - 8 months ago

Bright Minds Biosciences: A Buy With A Major Catalyst In Q2 2025

Jan 26, 2025, 6:32 AM EST - 11 months ago

Bright Minds Biosciences: Looking To Change Scope Of Epilepsy Disorder Treatments With BMB-101

Jan 7, 2025, 6:50 AM EST - 11 months ago

Bright Minds Biosciences Appoints Pharmaceutical Leader, Stephen Collins, M.D., Ph.D., as Chief Medical Officer

Nov 13, 2024, 12:59 PM EST - 1 year ago

Meet the Biotech Stock That Has Generated Nvidia-Like Returns in Less Than a Month

Nov 4, 2024, 2:41 PM EST - 1 year ago

Bright Minds Biosciences Closes US$35 Million Non-Brokered Private Placement

Oct 30, 2024, 1:07 AM EDT - 1 year ago

Bright Minds Biosciences: BMB-101's Phase 2 Trials Could Unlock Epilepsy Market Potential

Oct 28, 2024, 8:21 AM EDT - 1 year ago

PESG Releases Market Update: Nuvectis Pharma Shows Promising Synergy for NXP900 in Recent Presentations; Growing Anticipation for Upcoming NXP800 Data Update

NVCT

Oct 21, 2024, 8:30 AM EDT - 1 year ago

Bright Minds Biosciences and Firefly Neuroscience to Collaborate After the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy for Full Analysis of EEG Data

Oct 18, 2024, 6:50 AM EDT - 1 year ago

Bright Minds Biosciences Announces US$35 Million Non-Brokered Private Placement

Oct 16, 2024, 10:45 AM EDT - 1 year ago

Bright Minds Biosciences proprietary compound, BMB-201, 5-HT2C/2A mixed agonist, demonstrated similar efficacy to morphine in preclinical pain models

Oct 15, 2024, 9:09 PM EDT - 1 year ago

Bright Minds is Unaware of Any Material Changes

Oct 3, 2024, 9:00 AM EDT - 1 year ago

Bright Minds Biosciences announces participation in upcoming scientific conferences and partnering events

Sep 19, 2024, 10:00 AM EDT - 1 year ago

Bright Minds Biosciences to Host Investor & Analyst KOL Event on September 25th

Sep 12, 2024, 8:00 AM EDT - 1 year ago

Bright Minds Biosciences Initiates the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy

Aug 8, 2023, 6:50 AM EDT - 2 years ago

Bright Minds Biosciences Announces Positive qEEG (Quantitative Electroencephalogram) Data from its First-in-Human Phase 1 Study of Lead Compound, BMB-101

Jul 20, 2023, 6:50 AM EDT - 2 years ago

Bright Minds Biosciences Announces Positive Topline Data for its First-in-Human Phase 1 Study of Lead Compound, BMB-101

Jul 12, 2023, 10:33 AM EDT - 2 years ago

CSE Bulletin: Consolidation - Bright Minds Biosciences Inc. (DRUG)

Jul 11, 2023, 6:50 AM EDT - 2 years ago

Bright Minds Announces Effective Date of Share Consolidation

Jun 22, 2023, 6:50 AM EDT - 2 years ago

Bright Minds Announces Proposed Share Consolidation

Apr 19, 2023, 6:50 AM EDT - 2 years ago

Bright Minds Biosciences Receives a Favorable Written Opinion from the International Searching Authority for BMB-202

Apr 10, 2023, 6:50 AM EDT - 2 years ago

Bright Minds Biosciences to Present at the 20th International Meeting of the International Society for Serotonin Research

Feb 27, 2023, 6:50 AM EST - 3 years ago

Bright Minds Biosciences Provides Clinical Program Updates and Outlines Anticipated Milestones for 2023

Feb 17, 2023, 6:50 AM EST - 3 years ago

Bright Minds Biosciences Announces Non-Executive Director Appointment

Feb 8, 2023, 4:05 PM EST - 3 years ago

Bright Minds Biosciences Announces Receipt of Nasdaq Deficiency Letter Regarding Independent Director and Audit Committee Requirements

Jan 27, 2023, 4:05 PM EST - 3 years ago

Bright Minds Biosciences Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

Jan 9, 2023, 4:05 PM EST - 3 years ago

Bright Minds Biosciences Announces Resignation of Board Member

Dec 2, 2022, 7:07 PM EST - 3 years ago

Bright Minds Biosciences Announces Closing of Non-Brokered Private Placement

Nov 28, 2022, 6:50 AM EST - 3 years ago

Bright Minds Biosciences Announces Non-Brokered Private Placement

Nov 23, 2022, 11:35 AM EST - 3 years ago

Bright Minds Biosciences Appoints Drug Development Executive Mark A. Smith M.D.

Sep 7, 2022, 6:50 AM EDT - 3 years ago

Bright Minds Biosciences Announces Appointment of Doug Williamson to Board of Directors

Aug 31, 2022, 6:50 AM EDT - 3 years ago

Bright Minds Biosciences Initiates Dosing in Phase I Clinical Trial of BMB-101 for Dravet Syndrome

Aug 30, 2022, 3:35 PM EDT - 3 years ago

Bright Minds Biosciences Announces Closing of $4 Million Unit Offering

Aug 23, 2022, 9:07 PM EDT - 3 years ago

Bright Minds Announces Pricing of Overnight Marketed Offering of Units

Aug 22, 2022, 7:05 PM EDT - 3 years ago

Bright Minds Announces Overnight Marketed Offering of Units

Aug 18, 2022, 3:34 PM EDT - 3 years ago

Bright Minds Biosciences Comments on Recent Trading Activity

Jun 27, 2022, 6:50 AM EDT - 3 years ago

Bright Minds Biosciences Announces Changes to its Executive Leadership Team, Marking the Transition to a Development Organization

May 12, 2022, 6:50 AM EDT - 3 years ago

Bright Minds Biosciences to Host Key Opinion Leader Symposium on Dravet Syndrome

May 2, 2022, 6:50 AM EDT - 3 years ago

Bright Minds Biosciences Establishes Scientific Advisory Board, Comprising Five Preeminent Physicians and Scientists Across Mental Health Specialties

Nov 30, 2021, 7:30 AM EST - 4 years ago

Bright Minds Biosciences Provides Scientific Update on its Novel 5-HT2A Psychedelic Program for the Treatment of Mental Diseases

Nov 4, 2021, 8:52 AM EDT - 4 years ago

Bright Minds Biosciences: Newest Psychedelics Company To Join The Nasdaq

Nov 3, 2021, 6:50 AM EDT - 4 years ago

Bright Minds Biosciences Commences Trading on the Nasdaq Under the Ticker Symbol “DRUG”

BiotechBonesaw Dec. 4 at 8:58 PM

$VKTX $QNTM $IMRX $DRUG get ready 😳 https://www.investors.com/news/technology/medical-stocks-biotech-stocks-research-stocks-fda-clinical-trials/

0 · Reply

Stock_Catcher Dec. 4 at 2:56 AM

Money Thursday Watchlist Pt 9 $BBBY $ETHZ $OGEN $OPGN $DRUG Let's Ride Tomorrow 📈

0 · Reply

dbr_island Dec. 3 at 11:14 PM

$PLRZ told you this was a special ticker $EPOW will be another special one that will go BOOM I even called $DRUG in the $2’s👇💰💰💰💰 MARK THIS POST $KITT $KALA

0 · Reply

dbr_island Dec. 3 at 10:57 PM

$DRUG as you can see below I see things others don’t That’s why I’m POUNDING the table on $EPOW 🚨👇 WATCH AND LEARN $GNS $BURU $IXHL let’s keep going bulls

1 · Reply

dbr_island Dec. 3 at 10:49 PM

0 · Reply

Doozio Dec. 3 at 3:29 PM

All the $DRUG zzzz out of the 1st 🐑 correction of 🐒🍌🧠⏰♾️

0 · Reply

Stock__Hunter Dec. 2 at 8:44 PM

$DRUG top of line ticker name.. pro tip.. stay away from junkie ticker names

0 · Reply

Stock__Hunter Dec. 2 at 8:41 PM

$DRUG Biosciences need more... bio.. drug...

0 · Reply

PolycarpFX Dec. 2 at 8:28 PM

$DRUG printed an important BLOCK on a DARK POOL on 2025-12-02 @ 14:58:00 EST via @_VolumeLeaders_

0 · Reply

Doozio Dec. 2 at 5:27 PM

What if da $DRUG zzzzz are $YEXT ?

0 · Reply

SannieVerraderlijk Dec. 2 at 4:42 PM

$DRUG Surprisingly strong today

0 · Reply

Quantumup Dec. 1 at 1:47 PM

Cantor reiterated $DRUG at an Overweight rating ZGNX - $UCBJY LBPH - $HLUBF / $HLBBF Here's what Cantor had to say:

0 · Reply

nothingsnew Nov. 28 at 5:37 PM

$DRUG look at IINN

0 · Reply

Alessandro437 Nov. 28 at 4:05 PM

$KTTA this is the next $DRUG ☢️🚀

1 · Reply

Doozio Nov. 26 at 3:21 PM

$ARWR are the $DRUG zzzzzz YEXT? 🐒🍌🧠⏰♾️

0 · Reply

dbr_island Nov. 25 at 8:20 PM

$INM 🚨ATTENTION🚨 IF THIS DOESNT HIT AT LEAST $2 YOU CAN TAKE MY CROWN 👑 DEAL? You ignored me at $DRUG $CETY $RUBI $OSRH 🔥 DO NOT IGNORE INM 🔥

1 · Reply

StockMasterHere Nov. 21 at 3:34 PM

$PCSA Took a starter - will be loading heavy. LFG $INTS $DRUG

0 · Reply

kmonaco Nov. 19 at 5:42 PM

$SGBX $DRUG $SGBX READY TO GO LIKE $WSHP

0 · Reply

Packyman4 Nov. 19 at 5:37 PM

$SGBX is this right? A little pump and this gets a mega $DRUG like sqeeze to possibly $100? That would be sweet😁🚀🚀🐳🤣

0 · Reply

aubriellePineda91 Nov. 19 at 5:21 PM

$DRUG + AI? Their partnership (or data‑driven approach) could be a multiplier.

0 · Reply

damirWeber92 Nov. 19 at 5:13 PM

$DRUG (Bright Minds Biosciences) has neuro‑psychiatric pipeline — very asymmetric risk / reward.

0 · Reply

Stock__Hunter Nov. 18 at 10:02 PM

$OLMA algo run em.. in 2/5/10/20 baggers and if your luckY bio/$DRUG 50 MAX

0 · Reply

Market Cap	547.65M
Revenue (ttm)	0.00
Net Income (ttm)	-2.06M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	125,300
Avg Vol	153,398
Day's Range	N/A - N/A
Shares Out	7.79M
Stochastic %K	90%
Beta	-6.22
Analysts	Strong Sell
Price Target	$82.40